Skip to content
2000
Volume 13, Issue 8
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

Small molecules that modulate histone acetylation by targeting key enzymes mediating this posttranslational modification – histone acetyltransferases and histone deacetylases – are validated chemotherapeutic agents for the treatment of cancer. This area of research has seen a rapid increase in interest in the past decade, with the structurally diverse natural products-derived compounds at its forefront. These secondary metabolites from various biological sources target this epigenetic modification through distinct mechanisms of enzyme regulation by utilizing a diverse array of pharmacophores. We review the discovery of these compounds and discuss their modes of inhibition together with their downstream biological effects.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/138945012802008973
2012-07-01
2025-09-29
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/138945012802008973
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test